Status:
UNKNOWN
Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The island of Reunion, a French overseas department of 860,000 inhabitants, located in the Indian Ocean (OI) zone, recorded its first case of COVID-19 on March 11, 2020. The epidemic, which was descri...
Eligibility Criteria
Inclusion
- over 18 years old
- having been hospitalized at the University Hospital Center (CHU) of Reunion (minimum of one night in the hospital)
- with a positive diagnosis of COVID-19 (positive RT(reverse transcription)-PCR(Polymerase Chain Reaction) SARS-CoV-2 on a nasopharyngeal swab or positive serology or confirmed diagnosis in the medical file)
- registered in the COVIDEPI database
- whose telephone numbers are available in the computerized patient file
- residing on the island of Reunion
- knowing how to understand and speak French
Exclusion
- deceased
- opposing the use of their data
- deprived of liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure: guardianship or curators
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT05413694
Start Date
July 1 2022
End Date
December 1 2024
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Réunion
Saint-Pierre, Reunion, 97448